Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk
- 1 February 2007
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 27 (4) , 1247-1253
- https://doi.org/10.1128/mcb.01621-06
Abstract
The multidrug transporter breast cancer resistance protein (BCRP/ABCG2) is strongly induced in the mammary gland during pregnancy and lactation. We here demonstrate that BCRP is responsible for pumping riboflavin (vitamin B(2)) into milk, thus supplying the young with this important nutrient. In Bcrp1(-/-) mice, milk secretion of riboflavin was reduced >60-fold compared to that in wild-type mice. Yet, under laboratory conditions, Bcrp1(-/-) pups showed no riboflavin deficiency due to concomitant milk secretion of its cofactor flavin adenine dinucleotide, which was not affected. Thus, two independent secretion mechanisms supply vitamin B(2) equivalents to milk. BCRP is the first active riboflavin efflux transporter identified in mammals and the first transporter shown to concentrate a vitamin into milk. BCRP activity elsewhere in the body protects against xenotoxins by reducing their absorption and mediating their excretion. Indeed, Bcrp1 activity increased excretion of riboflavin into the intestine and decreased its systemic availability in adult mice. Surprisingly, the paradoxical dual utilization of BCRP as a xenotoxin and a riboflavin pump is evolutionarily conserved among mammals as diverse as mice and humans. This study establishes the principle that an ABC transporter can transport a vitamin into milk and raises the possibility that other vitamins and nutrients are likewise secreted into milk by ABC transporters.Keywords
This publication has 23 references indexed in Scilit:
- The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxinsTrends in Pharmacological Sciences, 2006
- Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugsTrends in Pharmacological Sciences, 2006
- Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattleGenome Research, 2005
- Sex-Dependent Expression and Activity of the ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (BCRP/ABCG2) in LiverMolecular Pharmacology, 2005
- Mechanism of the Pharmacokinetic Interaction between Methotrexate and BenzimidazolesCancer Research, 2004
- Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) ExpressionJournal of Biological Chemistry, 2004
- Intestinal flora and endogenous vitamin synthesisEuropean Journal Of Cancer Prevention, 1997
- Determination of Riboflavin and Flavocoenzymes in Human Blood Plasma by High-Performance Liquid ChromatographyAnnals of Nutrition and Metabolism, 1995
- Identification of riboflavin transport by MDCK cells using quantitative fluorescence video microscopyThe Journal of Membrane Biology, 1990
- Riboflavin-methotrexate interactions: Photochemical reaction and competition for transport in the L1210 mouse leukemia cellBiochemical Pharmacology, 1970